Biotechnology
The Biotechnology industry has a total of 594 stocks, with a combined market cap of $1.09 trillion and total revenue of $110.33 billion.
Market Cap
1.09T
Revenue
110.33B
Profits
-41.09B
PE Ratio
n/a
Profit Margin
-37.24%
Dividend Yield
0.04%
594 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 116.01B | -0.90% | 1,171,554 | 12.00B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 77.98B | -0.66% | 561,903 | 14.34B |
| 3 | ARGX | argenx SE | 44.16B | -1.42% | 536,281 | 4.25B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 42.53B | 0.05% | 996,359 | 3.71B |
| 5 | ONC | BeOne Medicines AG | 33.41B | 2.79% | 298,131 | 5.34B |
| 6 | INSM | Insmed Incorporated | 30.21B | -2.40% | 2,169,932 | 606.42M |
| 7 | RPRX | Royalty Pharma plc | 26.20B | -0.59% | 2,700,878 | 2.38B |
| 8 | BNTX | BioNTech SE | 25.47B | -0.44% | 578,277 | 3.70B |
| 9 | MRNA | Moderna, Inc. | 20.74B | -2.43% | 12,482,476 | 1.94B |
| 10 | ROIV | Roivant Sciences Ltd. | 20.60B | -3.16% | 5,686,404 | 13.31M |
| 11 | RVMD | Revolution Medicines, Inc. | 19.50B | -1.24% | 1,601,103 | - |
| 12 | INCY | Incyte Corporation | 19.09B | -1.43% | 1,254,915 | 5.14B |
| 13 | GMAB | Genmab A/S | 16.50B | -1.53% | 2,541,842 | 3.72B |
| 14 | ASND | Ascendis Pharma A/S | 14.77B | 1.39% | 559,272 | 845.52M |
| 15 | BBIO | BridgeBio Pharma, Inc. | 12.67B | -1.22% | 3,243,752 | 502.08M |
| 16 | IONS | Ionis Pharmaceuticals, Inc. | 12.23B | -1.49% | 1,904,127 | 943.71M |
| 17 | BMRN | BioMarin Pharmaceutical Inc. | 11.75B | 0.91% | 2,630,503 | 3.22B |
| 18 | SMMT | Summit Therapeutics Inc. | 11.72B | 1.14% | 2,307,378 | - |
| 19 | JAZZ | Jazz Pharmaceuticals plc | 11.20B | -0.88% | 982,764 | 4.27B |
| 20 | EXEL | Exelixis, Inc. | 10.79B | 0.64% | 2,712,980 | 2.32B |
| 21 | MDGL | Madrigal Pharmaceuticals, Inc. | 9.93B | -1.48% | 476,026 | 958.40M |
| 22 | IBRX | ImmunityBio, Inc. | 8.91B | -3.24% | 23,018,213 | 113.29M |
| 23 | PRAX | Praxis Precision Medicines, Inc. | 8.65B | 0.04% | 222,060 | 7.46M |
| 24 | PCVX | Vaxcyte, Inc. | 8.53B | 1.79% | 1,445,160 | - |
| 25 | ABVX | ABIVAX Société Anonyme | 8.49B | -2.99% | 823,192 | 6.23M |
| 26 | TECH | Bio-Techne Corporation | 8.43B | -3.58% | 3,064,168 | 1.22B |
| 27 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.38B | -5.94% | 2,820,263 | 1.09B |
| 28 | AXSM | Axsome Therapeutics, Inc. | 8.30B | 0.54% | 386,927 | 638.50M |
| 29 | HALO | Halozyme Therapeutics, Inc. | 7.95B | 0.01% | 1,263,253 | 1.40B |
| 30 | NUVL | Nuvalent, Inc. | 7.82B | -0.72% | 462,647 | - |
| 31 | CYTK | Cytokinetics, Incorporated | 7.44B | -2.86% | 1,788,344 | 88.04M |
| 32 | KRYS | Krystal Biotech, Inc. | 7.42B | -2.55% | 244,380 | 389.13M |
| 33 | KYMR | Kymera Therapeutics, Inc. | 6.82B | -0.04% | 557,255 | 39.21M |
| 34 | ACLX | Arcellx, Inc. | 6.69B | -0.03% | 1,184,178 | 22.29M |
| 35 | BLTE | Belite Bio, Inc | 6.50B | 0.42% | 135,872 | - |
| 36 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.39B | 2.25% | 629,422 | 189.76M |
| 37 | COGT | Cogent Biosciences, Inc. | 5.97B | -1.01% | 2,998,158 | - |
| 38 | PTGX | Protagonist Therapeutics, Inc. | 5.88B | 0.74% | 572,368 | 46.02M |
| 39 | IMVT | Immunovant, Inc. | 5.43B | -0.22% | 938,899 | - |
| 40 | CRSP | CRISPR Therapeutics AG | 5.42B | -1.45% | 1,167,774 | 3.51M |
| 41 | CELC | Celcuity Inc. | 5.32B | -0.21% | 799,095 | - |
| 42 | CAI | Caris Life Sciences, Inc. | 5.25B | -3.28% | 1,772,870 | 812.03M |
| 43 | CGON | CG Oncology, Inc. | 5.22B | 2.50% | 1,025,926 | 4.04M |
| 44 | MIRM | Mirum Pharmaceuticals, Inc. | 5.21B | -1.75% | 599,491 | 521.31M |
| 45 | SRRK | Scholar Rock Holding Corporation | 5.20B | -1.86% | 1,470,993 | - |
| 46 | PTCT | PTC Therapeutics, Inc. | 5.20B | -0.81% | 1,225,180 | 1.73B |
| 47 | APGE | Apogee Therapeutics, Inc. | 5.03B | 3.00% | 607,065 | - |
| 48 | ERAS | Erasca, Inc. | 4.79B | -0.45% | 5,052,072 | - |
| 49 | TERN | Terns Pharmaceuticals, Inc. | 4.66B | 1.95% | 1,804,364 | - |
| 50 | FOLD | Amicus Therapeutics, Inc. | 4.50B | 0.07% | 2,992,449 | 634.21M |
| 51 | TGTX | TG Therapeutics, Inc. | 4.32B | 0.83% | 1,208,130 | 616.29M |
| 52 | GPCR | Structure Therapeutics Inc. | 4.09B | -3.30% | 820,444 | - |
| 53 | LGND | Ligand Pharmaceuticals Incorporated | 4.03B | -2.12% | 188,510 | 268.09M |
| 54 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.00B | -1.72% | 1,417,941 | 7.70M |
| 55 | VKTX | Viking Therapeutics, Inc. | 3.81B | 4.67% | 2,973,904 | - |
| 56 | CNTA | Centessa Pharmaceuticals plc | 3.79B | -1.48% | 1,039,138 | 15.00M |
| 57 | ACAD | ACADIA Pharmaceuticals Inc. | 3.78B | -1.07% | 1,324,038 | 1.07B |
| 58 | ADMA | ADMA Biologics, Inc. | 3.67B | -1.97% | 3,099,302 | 510.17M |
| 59 | CORT | Corcept Therapeutics Incorporated | 3.60B | -0.50% | 1,229,784 | 761.41M |
| 60 | LEGN | Legend Biotech Corporation | 3.50B | 6.87% | 1,879,221 | 909.05M |
| 61 | XENE | Xenon Pharmaceuticals Inc. | 3.49B | -0.26% | 1,084,868 | 7.50M |
| 62 | NAMS | NewAmsterdam Pharma Company N.V. | 3.43B | -0.93% | 1,042,025 | 22.50M |
| 63 | ALMS | Alumis Inc. | 3.35B | -2.68% | 1,277,255 | 22.12M |
| 64 | SYRE | Spyre Therapeutics, Inc. | 3.15B | -1.08% | 567,497 | - |
| 65 | DNLI | Denali Therapeutics Inc. | 3.12B | -0.05% | 1,260,637 | - |
| 66 | TARS | Tarsus Pharmaceuticals, Inc. | 3.12B | -2.19% | 757,248 | 451.36M |
| 67 | EWTX | Edgewise Therapeutics, Inc. | 2.98B | -2.01% | 1,170,075 | - |
| 68 | ARQT | Arcutis Biotherapeutics, Inc. | 2.98B | 0.13% | 1,112,778 | 376.07M |
| 69 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.96B | -0.33% | 654,696 | 588.99M |
| 70 | IDYA | IDEAYA Biosciences, Inc. | 2.91B | 0.48% | 727,689 | 218.71M |
| 71 | VRDN | Viridian Therapeutics, Inc. | 2.90B | -1.90% | 1,198,475 | 70.85M |
| 72 | DNTH | Dianthus Therapeutics, Inc. | 2.82B | 6.14% | 1,184,600 | 3.08M |
| 73 | VERA | Vera Therapeutics, Inc. | 2.79B | 0.57% | 1,015,960 | - |
| 74 | RCUS | Arcus Biosciences, Inc. | 2.77B | -0.45% | 654,352 | 247.00M |
| 75 | BEAM | Beam Therapeutics Inc. | 2.64B | 4.00% | 1,608,114 | 139.74M |
| 76 | APLS | Apellis Pharmaceuticals, Inc. | 2.57B | -0.40% | 1,627,196 | 1.00B |
| 77 | TLX | Telix Pharmaceuticals Limited | 2.56B | 5.47% | 515,913 | 803.79M |
| 78 | TVTX | Travere Therapeutics, Inc. | 2.51B | -0.26% | 1,433,738 | 490.73M |
| 79 | WVE | Wave Life Sciences Ltd. | 2.47B | -0.61% | 2,472,826 | 42.73M |
| 80 | DYN | Dyne Therapeutics, Inc. | 2.45B | -2.24% | 2,592,869 | - |
| 81 | TNGX | Tango Therapeutics, Inc. | 2.42B | 0.71% | 8,096,910 | 62.38M |
| 82 | IMNM | Immunome, Inc. | 2.38B | 0.43% | 1,831,806 | 6.94M |
| 83 | IRON | Disc Medicine, Inc. | 2.33B | 1.39% | 761,473 | - |
| 84 | ADPT | Adaptive Biotechnologies Corporation | 2.29B | -6.72% | 1,973,846 | 276.98M |
| 85 | OCUL | Ocular Therapeutix, Inc. | 2.24B | -0.58% | 5,611,234 | 51.95M |
| 86 | DAWN | Day One Biopharmaceuticals, Inc. | 2.19B | 65.88% | 78,372,872 | 158.18M |
| 87 | ZLAB | Zai Lab Limited | 2.19B | 1.24% | 720,786 | 460.16M |
| 88 | MAZE | Maze Therapeutics, Inc. | 2.16B | -1.04% | 383,490 | 2.50M |
| 89 | GLPG | Galapagos NV | 2.15B | -1.38% | 130,049 | 1.31B |
| 90 | AAPG | Ascentage Pharma Group International | 2.13B | 3.72% | 372 | 54.52M |
| 91 | IOVA | Iovance Biotherapeutics, Inc. | 2.11B | 12.01% | 44,562,758 | 263.50M |
| 92 | MLYS | Mineralys Therapeutics, Inc. | 2.10B | -0.49% | 1,343,087 | - |
| 93 | MESO | Mesoblast Limited | 2.08B | 1.08% | 296,431 | 65.38M |
| 94 | RARE | Ultragenyx Pharmaceutical Inc. | 2.05B | -0.98% | 2,148,366 | 673.00M |
| 95 | SLNO | Soleno Therapeutics, Inc. | 2.05B | 2.88% | 1,756,233 | 190.41M |
| 96 | STOK | Stoke Therapeutics, Inc. | 2.03B | 2.40% | 1,833,479 | 205.63M |
| 97 | NKTR | Nektar Therapeutics | 1.98B | -2.42% | 736,625 | 62.60M |
| 98 | CLDX | Celldex Therapeutics, Inc. | 1.96B | 0.24% | 541,004 | 1.55M |
| 99 | SNDX | Syndax Pharmaceuticals, Inc. | 1.95B | 2.27% | 1,390,255 | 172.35M |
| 100 | AUPH | Aurinia Pharmaceuticals Inc. | 1.90B | -2.85% | 992,717 | 283.06M |
| 101 | TYRA | Tyra Biosciences, Inc. | 1.89B | 1.45% | 1,533,898 | - |
| 102 | RXRX | Recursion Pharmaceuticals, Inc. | 1.83B | -2.26% | 12,177,791 | 74.68M |
| 103 | MANE | Veradermics, Incorporated | 1.81B | -0.12% | 305,704 | - |
| 104 | PVLA | Palvella Therapeutics, Inc. | 1.81B | -0.41% | 177,258 | - |
| 105 | ZYME | Zymeworks Inc. | 1.78B | -2.90% | 1,233,014 | 105.97M |
| 106 | RLAY | Relay Therapeutics, Inc. | 1.77B | 2.59% | 1,419,980 | 15.36M |
| 107 | DFTX | Definium Therapeutics, Inc. | 1.76B | 0.63% | 957,209 | - |
| 108 | ELVN | Enliven Therapeutics, Inc. | 1.76B | 0.51% | 563,969 | - |
| 109 | SRPT | Sarepta Therapeutics, Inc. | 1.75B | 2.96% | 3,067,485 | 2.20B |
| 110 | GLTO | Galecto, Inc. | 1.74B | 1.94% | 132,563 | - |
| 111 | VCEL | Vericel Corporation | 1.71B | -0.85% | 413,187 | 276.26M |
| 112 | TRVI | Trevi Therapeutics, Inc. | 1.71B | 1.68% | 1,113,500 | - |
| 113 | OLMA | Olema Pharmaceuticals, Inc. | 1.70B | -4.48% | 1,125,040 | - |
| 114 | PHVS | Pharvaris N.V. | 1.68B | 0.27% | 177,792 | - |
| 115 | IMCR | Immunocore Holdings plc | 1.67B | 3.26% | 907,430 | 400.02M |
| 116 | HRMY | Harmony Biosciences Holdings, Inc. | 1.64B | -0.63% | 738,162 | 868.45M |
| 117 | INVA | Innoviva, Inc. | 1.63B | -0.68% | 564,271 | 411.33M |
| 118 | NVAX | Novavax, Inc. | 1.63B | -0.10% | 3,884,728 | 1.12B |
| 119 | SION | Sionna Therapeutics, Inc. | 1.62B | 3.96% | 310,437 | - |
| 120 | AGIO | Agios Pharmaceuticals, Inc. | 1.61B | -0.76% | 855,829 | 54.03M |
| 121 | NBTX | Nanobiotix S.A. | 1.61B | 1.46% | 59,278 | 11.93M |
| 122 | ORKA | Oruka Therapeutics, Inc. | 1.60B | -0.60% | 242,116 | - |
| 123 | ANAB | AnaptysBio, Inc. | 1.59B | -3.26% | 492,565 | 234.60M |
| 124 | OCS | Oculis Holding AG | 1.59B | -2.81% | 266,966 | 1.51M |
| 125 | NTLA | Intellia Therapeutics, Inc. | 1.59B | 2.21% | 3,322,766 | 67.67M |
| 126 | NUVB | Nuvation Bio Inc. | 1.57B | 0.44% | 6,331,343 | 62.90M |
| 127 | NRIX | Nurix Therapeutics, Inc. | 1.55B | -0.79% | 632,808 | 83.98M |
| 128 | KOD | Kodiak Sciences Inc. | 1.54B | -1.19% | 528,313 | - |
| 129 | VIR | Vir Biotechnology, Inc. | 1.53B | 4.95% | 4,013,049 | 68.56M |
| 130 | ARDX | Ardelyx, Inc. | 1.52B | -1.28% | 2,675,658 | 407.32M |
| 131 | BHVN | Biohaven Ltd. | 1.49B | -3.78% | 2,221,590 | - |
| 132 | CAPR | Capricor Therapeutics, Inc. | 1.44B | 8.06% | 2,347,150 | 11.13M |
| 133 | RAPP | Rapport Therapeutics, Inc. | 1.44B | 1.99% | 370,725 | - |
| 134 | MBX | MBX Biosciences, Inc. | 1.44B | -2.83% | 591,573 | - |
| 135 | GENB | Generate Biomedicines, Inc. | 1.43B | -9.96% | 837,035 | 31.89M |
| 136 | GLUE | Monte Rosa Therapeutics, Inc. | 1.41B | -0.84% | 864,631 | 181.54M |
| 137 | ORIC | ORIC Pharmaceuticals, Inc. | 1.38B | -1.01% | 998,914 | - |
| 138 | ZBIO | Zenas BioPharma, Inc. | 1.36B | 0.08% | 291,690 | 15.00M |
| 139 | CRVS | Corvus Pharmaceuticals, Inc. | 1.32B | -1.65% | 1,403,091 | - |
| 140 | IMTX | Immatics N.V. | 1.32B | -2.86% | 223,835 | 56.67M |
| 141 | EYPT | EyePoint, Inc. | 1.31B | -0.06% | 1,893,477 | 31.37M |
| 142 | SVRA | Savara Inc. | 1.30B | -4.01% | 775,427 | - |
| 143 | MLTX | MoonLake Immunotherapeutics | 1.30B | 0.72% | 884,307 | - |
| 144 | SEPN | Septerna, Inc. | 1.29B | 4.77% | 302,120 | 22.05M |
| 145 | TSHA | Taysha Gene Therapies, Inc. | 1.25B | 1.78% | 1,962,569 | 6.31M |
| 146 | ATAI | AtaiBeckley Inc. | 1.23B | -4.24% | 7,360,465 | 4.09M |
| 147 | DBVT | DBV Technologies S.A. | 1.21B | -0.95% | 357,965 | 5.50M |
| 148 | BCAX | Bicara Therapeutics Inc. | 1.20B | -0.16% | 471,766 | - |
| 149 | PGEN | Precigen, Inc. | 1.17B | -1.48% | 2,403,962 | 6.31M |
| 150 | IVA | Inventiva S.A. | 1.15B | 1.32% | 210,736 | 19.93M |
| 151 | PHAR | Pharming Group N.V. | 1.06B | -2.46% | 15,470 | 362.27M |
| 152 | ABCL | AbCellera Biologics Inc. | 1.05B | -3.90% | 4,271,170 | 75.13M |
| 153 | AVBP | ArriVent BioPharma, Inc. | 1.04B | -7.21% | 1,790,814 | - |
| 154 | INBX | Inhibrx Biosciences, Inc. | 1.01B | -2.09% | 154,713 | 1.40M |
| 155 | XERS | Xeris Biopharma Holdings, Inc. | 1.00B | -3.81% | 1,796,071 | 291.85M |
| 156 | URGN | UroGen Pharma Ltd. | 996.04M | 4.33% | 1,225,609 | 109.79M |
| 157 | CMPX | Compass Therapeutics, Inc. | 992.28M | -0.36% | 1,845,033 | 850.00K |
| 158 | GHRS | GH Research PLC | 988.13M | 5.01% | 280,198 | - |
| 159 | AKTS | Aktis Oncology, Inc. | 987.94M | -8.42% | 212,754 | 5.56M |
| 160 | GERN | Geron Corporation | 980.03M | 7.75% | 18,971,048 | 183.88M |
| 161 | SLS | SELLAS Life Sciences Group, Inc. | 941.66M | 4.73% | 5,820,800 | - |
| 162 | CGEM | Cullinan Therapeutics, Inc. | 929.86M | 0.90% | 681,206 | - |
| 163 | VALN | Valneva SE | 920.15M | -5.31% | 17,856 | 211.09M |
| 164 | MRVI | Maravai LifeSciences Holdings, Inc. | 912.59M | -3.53% | 1,267,568 | 185.74M |
| 165 | FTRE | Fortrea Holdings Inc. | 898.54M | -3.13% | 1,248,292 | 2.72B |
| 166 | SPRY | ARS Pharmaceuticals, Inc. | 895.57M | -0.66% | 1,528,054 | 142.77M |
| 167 | SGP | SpyGlass Pharma, Inc. | 888.91M | 0.98% | 97,336 | - |
| 168 | QURE | uniQure N.V. | 888.90M | 33.99% | 17,626,304 | 16.10M |
| 169 | ABUS | Arbutus Biopharma Corporation | 871.23M | -3.62% | 3,371,376 | 14.61M |
| 170 | ARVN | Arvinas, Inc. | 869.87M | -0.87% | 814,336 | 262.60M |
| 171 | JANX | Janux Therapeutics, Inc. | 841.91M | -0.93% | 802,331 | 10.00M |
| 172 | PHAT | Phathom Pharmaceuticals, Inc. | 840.78M | -0.65% | 965,633 | 175.11M |
| 173 | SANA | Sana Biotechnology, Inc. | 840.63M | -7.62% | 3,828,891 | - |
| 174 | EVMN | Evommune, Inc. | 835.39M | 5.62% | 282,649 | 13.00M |
| 175 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 833.48M | 5.36% | 370,268 | - |
| 176 | XNCR | Xencor, Inc. | 830.19M | 1.43% | 877,394 | 125.58M |
| 177 | KALV | KalVista Pharmaceuticals, Inc. | 820.37M | 0.12% | 671,640 | 1.43M |
| 178 | OMER | Omeros Corporation | 818.19M | 0.44% | 622,812 | - |
| 179 | MPLT | MapLight Therapeutics, Inc. | 807.80M | 3.06% | 115,503 | - |
| 180 | MNKD | MannKind Corporation | 804.14M | -7.77% | 9,457,112 | 348.97M |
| 181 | CTMX | CytomX Therapeutics, Inc. | 792.96M | -1.89% | 3,021,339 | 113.63M |
| 182 | KURA | Kura Oncology, Inc. | 791.43M | 5.29% | 1,992,090 | 67.48M |
| 183 | EIKN | Eikon Therapeutics, Inc. | 776.29M | -1.10% | 207,752 | - |
| 184 | ANNX | Annexon, Inc. | 769.13M | -4.97% | 1,792,668 | - |
| 185 | DRUG | Bright Minds Biosciences Inc. | 738.16M | -1.20% | 116,906 | - |
| 186 | LXRX | Lexicon Pharmaceuticals, Inc. | 730.31M | 4.27% | 4,901,076 | 49.80M |
| 187 | PRME | Prime Medicine, Inc. | 710.09M | 2.04% | 2,568,284 | 4.63M |
| 188 | GYRE | Gyre Therapeutics, Inc. | 700.76M | -1.53% | 219,419 | 107.27M |
| 189 | PROK | ProKidney Corp. | 691.92M | -2.13% | 399,004 | 744.00K |
| 190 | TBPH | Theravance Biopharma, Inc. | 687.62M | -0.07% | 1,178,200 | 80.33M |
| 191 | TECX | Tectonic Therapeutic, Inc. | 673.52M | 28.80% | 1,145,349 | - |
| 192 | MDXG | MiMedx Group, Inc. | 668.55M | -5.26% | 887,708 | 418.63M |
| 193 | REPL | Replimune Group, Inc. | 666.36M | 14.63% | 3,083,259 | - |
| 194 | AGMB | AgomAb Therapeutics NV | 663.79M | -4.15% | 152,600 | - |
| 195 | ZURA | Zura Bio Limited | 661.28M | 3.11% | 343,689 | - |
| 196 | JBIO | Jade Biosciences, Inc. | 646.36M | 1.22% | 299,141 | - |
| 197 | ANRO | Alto Neuroscience, Inc. | 644.94M | 0.87% | 218,452 | - |
| 198 | VOR | Vor Biopharma Inc. | 627.78M | 3.85% | 547,069 | - |
| 199 | LBRX | LB Pharmaceuticals Inc | 604.14M | 1.40% | 97,021 | - |
| 200 | ENGN | enGene Holdings Inc. | 581.47M | -0.34% | 154,824 | - |
| 201 | YDES | YD Bio Limited | 573.11M | -2.73% | 9,929 | 510.36K |
| 202 | DSGN | Design Therapeutics, Inc. | 572.49M | -0.40% | 165,479 | - |
| 203 | LRMR | Larimar Therapeutics, Inc. | 566.84M | - | 1,851,678 | - |
| 204 | MGTX | MeiraGTx Holdings plc | 563.44M | 0.14% | 308,810 | 27.42M |
| 205 | VSTM | Verastem, Inc. | 560.39M | 3.74% | 2,015,600 | 30.91M |
| 206 | DRTS | Alpha Tau Medical Ltd. | 546.54M | -9.97% | 265,626 | - |
| 207 | FULC | Fulcrum Therapeutics, Inc. | 544.12M | 0.12% | 773,095 | 80.00M |
| 208 | RIGL | Rigel Pharmaceuticals, Inc. | 533.32M | -2.20% | 354,349 | 294.28M |
| 209 | OCGN | Ocugen, Inc. | 527.90M | -7.47% | 5,628,703 | 4.41M |
| 210 | SLDB | Solid Biosciences Inc. | 525.89M | 20.32% | 4,808,013 | - |
| 211 | ALLO | Allogene Therapeutics, Inc. | 516.88M | -0.43% | 4,127,463 | 22.00K |
| 212 | PRTA | Prothena Corporation plc | 516.26M | 1.37% | 638,187 | 9.68M |
| 213 | NMRA | Neumora Therapeutics, Inc. | 513.21M | 0.67% | 1,075,887 | - |
| 214 | FBRX | Forte Biosciences, Inc. | 512.83M | -5.02% | 256,968 | - |
| 215 | CRMD | CorMedix Inc. | 510.67M | 2.54% | 2,565,998 | 311.71M |
| 216 | ADCT | ADC Therapeutics SA | 509.13M | -1.91% | 541,307 | 75.21M |
| 217 | IVVD | Invivyd, Inc. | 507.58M | 3.45% | 3,000,350 | 53.43M |
| 218 | CTNM | Contineum Therapeutics, Inc. | 507.03M | 0.51% | 191,883 | - |
| 219 | ZVRA | Zevra Therapeutics, Inc. | 505.55M | 2.16% | 819,522 | 84.39M |
| 220 | LXEO | Lexeo Therapeutics, Inc. | 499.96M | 1.33% | 1,364,927 | - |
| 221 | IMMX | Immix Biopharma, Inc. | 489.54M | 8.78% | 1,113,334 | - |
| 222 | EPRX | Eupraxia Pharmaceuticals Inc. | 481.69M | 0.63% | 290,313 | - |
| 223 | RCKT | Rocket Pharmaceuticals, Inc. | 478.79M | -4.96% | 4,533,477 | - |
| 224 | LYEL | Lyell Immunopharma, Inc. | 477.14M | 1.86% | 42,370 | 41.00K |
| 225 | AVIR | Atea Pharmaceuticals, Inc. | 469.27M | 11.13% | 1,468,055 | - |
| 226 | VNDA | Vanda Pharmaceuticals Inc. | 466.36M | -0.25% | 942,468 | 216.11M |
| 227 | KYTX | Kyverna Therapeutics, Inc. | 462.75M | -3.46% | 881,460 | - |
| 228 | ALT | Altimmune, Inc. | 460.45M | 1.00% | 5,385,353 | 41.00K |
| 229 | IPSC | Century Therapeutics, Inc. | 459.90M | - | 928,267 | 113.34M |
| 230 | TRDA | Entrada Therapeutics, Inc. | 452.88M | 8.26% | 465,471 | 25.42M |
| 231 | LCTX | Lineage Cell Therapeutics, Inc. | 448.31M | 0.54% | 1,650,711 | 14.56M |
| 232 | ASMB | Assembly Biosciences, Inc. | 447.15M | 2.21% | 90,647 | 37.19M |
| 233 | RGNX | REGENXBIO Inc. | 446.45M | -0.80% | 1,383,917 | 170.44M |
| 234 | VTVT | vTv Therapeutics Inc. | 437.04M | -5.37% | 85,427 | 17.00K |
| 235 | TENX | Tenax Therapeutics, Inc. | 433.70M | -9.71% | 208,983 | - |
| 236 | FDMT | 4D Molecular Therapeutics, Inc. | 432.55M | -1.85% | 516,914 | 120.00K |
| 237 | AVXL | Anavex Life Sciences Corp. | 430.92M | -2.31% | 1,206,812 | - |
| 238 | STRO | Sutro Biopharma, Inc. | 414.45M | 12.40% | 264,821 | 105.65M |
| 239 | UPB | Upstream Bio, Inc. | 413.94M | -0.13% | 702,477 | 2.80M |
| 240 | DMAC | DiaMedica Therapeutics Inc. | 413.09M | 1.58% | 164,423 | - |
| 241 | IMMP | Immutep Limited | 408.45M | 1.81% | - | 5.28M |
| 242 | NAGE | Niagen Bioscience, Inc. | 406.05M | -0.78% | 2,431,653 | 129.42M |
| 243 | NBP | NovaBridge Biosciences | 403.52M | -3.85% | 1,583,666 | - |
| 244 | AUTL | Autolus Therapeutics plc | 401.88M | 1.68% | 1,830,995 | 51.13M |
| 245 | CBIO | Crescent Biopharma, Inc. | 400.89M | 6.53% | 156,623 | 10.84M |
| 246 | PRTC | PureTech Health plc | 400.20M | -2.27% | 3,726 | 6.39M |
| 247 | ENTA | Enanta Pharmaceuticals, Inc. | 392.92M | -1.46% | 144,091 | 66.98M |
| 248 | PEPG | PepGen Inc. | 390.83M | 3.18% | 584,615 | - |
| 249 | BNTC | Benitec Biopharma Inc. | 388.45M | 6.98% | 251,959 | - |
| 250 | ARMP | Armata Pharmaceuticals, Inc. | 385.91M | -3.28% | 36,732 | 5.05M |
| 251 | MNPR | Monopar Therapeutics Inc. | 384.05M | 2.99% | 169,583 | - |
| 252 | STTK | Shattuck Labs, Inc. | 379.05M | 17.45% | 2,520,567 | 1.00M |
| 253 | DNA | Ginkgo Bioworks Holdings, Inc. | 378.35M | -4.97% | 940,284 | 170.16M |
| 254 | ACRS | Aclaris Therapeutics, Inc. | 369.02M | -1.92% | 1,209,755 | 7.83M |
| 255 | LENZ | LENZ Therapeutics, Inc. | 365.15M | -3.23% | 523,462 | 17.50M |
| 256 | CADL | Candel Therapeutics, Inc. | 361.84M | 1.86% | 1,006,376 | - |
| 257 | BCYC | Bicycle Therapeutics plc | 360.71M | -2.80% | 274,262 | 28.34M |
| 258 | ABSI | Absci Corporation | 357.88M | -8.11% | 4,662,347 | 2.82M |
| 259 | AURA | Aura Biosciences, Inc. | 355.62M | -1.75% | 188,950 | - |
| 260 | IMRX | Immuneering Corporation | 344.16M | 7.03% | 969,700 | - |
| 261 | NGNE | Neurogene Inc. | 343.41M | 0.18% | 93,787 | 925.00K |
| 262 | CLYM | Climb Bio, Inc. | 342.81M | -2.84% | 491,599 | - |
| 263 | FHTX | Foghorn Therapeutics Inc. | 338.60M | 2.48% | 161,996 | 24.52M |
| 264 | IRD | Opus Genetics, Inc. | 337.23M | 2.52% | 1,518,451 | 14.63M |
| 265 | ANL | Adlai Nortye Ltd. | 328.78M | -3.57% | 175,127 | -1.35M |
| 266 | XFOR | X4 Pharmaceuticals, Inc. | 328.76M | 1.62% | 282,179 | 33.98M |
| 267 | RLMD | Relmada Therapeutics, Inc. | 326.33M | 0.45% | 450,015 | - |
| 268 | RZLT | Rezolute, Inc. | 323.04M | -0.64% | 1,292,691 | - |
| 269 | AVTX | Avalo Therapeutics, Inc. | 320.46M | -1.54% | 436,119 | 192.00K |
| 270 | GLSI | Greenwich LifeSciences, Inc. | 319.90M | -6.40% | 210,777 | - |
| 271 | TARA | Protara Therapeutics, Inc. | 316.16M | 1.37% | 1,098,634 | - |
| 272 | NAUT | Nautilus Biotechnology, Inc. | 312.61M | 1.23% | 89,223 | - |
| 273 | XOMA | XOMA Royalty Corporation | 308.86M | -1.25% | 194,071 | 47.11M |
| 274 | PBYI | Puma Biotechnology, Inc. | 307.80M | -2.89% | 374,627 | 228.37M |
| 275 | CABA | Cabaletta Bio, Inc. | 305.16M | -0.31% | 1,408,454 | - |
| 276 | CCCC | C4 Therapeutics, Inc. | 296.64M | 0.33% | 1,845,152 | 35.95M |
| 277 | SLN | Silence Therapeutics plc | 294.27M | 13.27% | 313,079 | 559.00K |
| 278 | ALXO | ALX Oncology Holdings Inc. | 289.95M | 3.76% | 1,223,817 | - |
| 279 | ALDX | Aldeyra Therapeutics, Inc. | 288.88M | 3.23% | 1,215,724 | - |
| 280 | CNTX | Context Therapeutics Inc. | 286.66M | 9.09% | 2,457,539 | - |
| 281 | ACIU | AC Immune SA | 276.05M | 2.20% | 211,043 | 5.48M |
| 282 | OABI | OmniAb, Inc. | 273.64M | -5.50% | 413,741 | 18.67M |
| 283 | CHRS | Coherus Oncology, Inc. | 272.04M | 3.41% | 1,641,141 | 277.73M |
| 284 | ENLV | Enlivex Ltd. | 270.61M | 1.79% | 188,142 | - |
| 285 | PRLD | Prelude Therapeutics Incorporated | 266.14M | 3.53% | 249,280 | 10.50M |
| 286 | CLLS | Cellectis S.A. | 265.08M | -2.73% | 42,632 | 82.55M |
| 287 | FENC | Fennec Pharmaceuticals Inc. | 262.98M | -2.90% | 141,097 | 38.79M |
| 288 | ABEO | Abeona Therapeutics Inc. | 262.83M | -0.41% | 1,147,465 | 400.00K |
| 289 | HELP | Cybin Inc. | 262.69M | -6.91% | 2,235,041 | - |
| 290 | NERV | Minerva Neurosciences, Inc. | 260.08M | 1.18% | 86,653 | - |
| 291 | IKT | Inhibikase Therapeutics, Inc. | 257.15M | -0.53% | 1,077,229 | 1.00 |
| 292 | OVID | Ovid Therapeutics Inc. | 248.65M | 3.24% | 2,156,562 | 6.61M |
| 293 | SRZN | Surrozen, Inc. | 248.55M | -6.75% | 122,457 | 3.60M |
| 294 | OBIO | Orchestra BioMed Holdings, Inc. | 243.93M | -4.21% | 91,311 | 2.82M |
| 295 | PALI | Palisade Bio, Inc. | 242.88M | -0.61% | 2,550,439 | - |
| 296 | NVCT | Nuvectis Pharma, Inc. | 237.37M | -0.88% | 80,862 | - |
| 297 | CNTN | Canton Strategic Holdings, Inc. | 230.80M | -0.44% | 318,879 | - |
| 298 | SLGL | Sol-Gel Technologies Ltd. | 227.45M | 3.35% | 63,992 | 18.97M |
| 299 | ACHV | Achieve Life Sciences, Inc. | 227.31M | -2.95% | 331,128 | - |
| 300 | KROS | Keros Therapeutics, Inc. | 222.81M | -3.50% | 654,516 | 244.06M |
| 301 | ALEC | Alector, Inc. | 220.73M | 1.01% | 684,086 | 21.05M |
| 302 | ELDN | Eledon Pharmaceuticals, Inc. | 220.60M | 6.11% | 2,145,745 | - |
| 303 | MDWD | MediWound Ltd. | 218.76M | -2.52% | 80,344 | 16.96M |
| 304 | CAMP | Camp4 Therapeutics Corporation | 217.90M | -8.50% | 36,211 | 3.50M |
| 305 | VYGR | Voyager Therapeutics, Inc. | 216.84M | -0.76% | 506,414 | 31.32M |
| 306 | HUMA | Humacyte, Inc. | 214.23M | 1.83% | 3,363,323 | 1.57M |
| 307 | CBUS | Cibus, Inc. | 213.48M | -1.86% | 194,110 | 3.79M |
| 308 | PLX | Protalix BioTherapeutics, Inc. | 210.70M | -5.76% | 883,378 | 61.84M |
| 309 | PMN | ProMIS Neurosciences, Inc. | 209.84M | -5.61% | 66,733 | - |
| 310 | ELTX | Elicio Therapeutics, Inc. | 203.23M | -1.61% | 167,175 | - |
| 311 | ARCT | Arcturus Therapeutics Holdings Inc. | 202.09M | -1.93% | 485,993 | 82.03M |
| 312 | ABOS | Acumen Pharmaceuticals, Inc. | 200.50M | -0.90% | 211,622 | - |
| 313 | GALT | Galectin Therapeutics Inc. | 199.87M | 2.31% | 350,365 | - |
| 314 | EDIT | Editas Medicine, Inc. | 195.24M | 5.54% | 2,269,722 | 46.38M |
| 315 | CGEN | Compugen Ltd. | 194.55M | 1.46% | 190,678 | 72.76M |
| 316 | TNYA | Tenaya Therapeutics, Inc. | 192.26M | 8.39% | 11,348,455 | - |
| 317 | NTHI | NeOnc Technologies Holdings, Inc. | 188.04M | 0.32% | 55,569 | 59.99K |
| 318 | PRQR | ProQR Therapeutics N.V. | 187.51M | 5.33% | 354,531 | 18.86M |
| 319 | MOLN | Molecular Partners AG | 187.40M | 1.52% | 1,490 | 856.30K |
| 320 | KLRS | Kalaris Therapeutics, Inc. | 183.66M | 1.50% | 41,240 | - |
| 321 | HRTX | Heron Therapeutics, Inc. | 182.24M | -5.24% | 3,651,360 | 154.90M |
| 322 | SABS | SAB Biotherapeutics, Inc. | 180.43M | -0.52% | 155,905 | 114.70K |
| 323 | RNAC | Cartesian Therapeutics, Inc. | 178.12M | -0.44% | 180,212 | 1.09M |
| 324 | NKTX | Nkarta, Inc. | 177.57M | 1.63% | 674,428 | - |
| 325 | TLSA | Tiziana Life Sciences Ltd | 177.40M | -3.47% | 118,908 | - |
| 326 | VXRT | Vaxart, Inc. | 177.33M | 2.41% | - | 148.20M |
| 327 | WHWK | Whitehawk Therapeutics, Inc. | 176.73M | 5.04% | 304,531 | 14.38M |
| 328 | SGMT | Sagimet Biosciences Inc. | 175.94M | -0.73% | 239,438 | - |
| 329 | TNXP | Tonix Pharmaceuticals Holding Corp. | 172.08M | -1.97% | 279,475 | 10.30M |
| 330 | CRBU | Caribou Biosciences, Inc. | 170.11M | 6.43% | 1,294,543 | 11.16M |
| 331 | MENS | Jyong Biotech Ltd. | 166.10M | -1.82% | 265,687 | - |
| 332 | KPTI | Karyopharm Therapeutics Inc. | 160.88M | -0.57% | 725,150 | 146.07M |
| 333 | MIST | Milestone Pharmaceuticals Inc. | 160.50M | -0.63% | 759,961 | - |
| 334 | IMUX | Immunic, Inc. | 160.47M | 10.81% | 3,353,548 | - |
| 335 | RANI | Rani Therapeutics Holdings, Inc. | 157.98M | -2.99% | 744,236 | 1.20M |
| 336 | FATE | Fate Therapeutics, Inc. | 154.63M | -3.62% | 1,762,707 | 6.65M |
| 337 | IPHA | Innate Pharma S.A. | 151.10M | 3.30% | 4,831 | 14.84M |
| 338 | ZNTL | Zentalis Pharmaceuticals, Inc. | 148.60M | 5.03% | 614,143 | 26.87M |
| 339 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 148.41M | -0.12% | 164,935 | - |
| 340 | UNCY | Unicycive Therapeutics, Inc. | 141.63M | -3.51% | 691,916 | - |
| 341 | MGNX | MacroGenics, Inc. | 141.07M | 4.21% | 947,264 | 127.63M |
| 342 | ARTV | Artiva Biotherapeutics, Inc. | 140.89M | - | 140,219 | 251.00K |
| 343 | SGMO | Sangamo Therapeutics, Inc. | 140.31M | 0.16% | 4,801,388 | 32.88M |
| 344 | CNTB | Connect Biopharma Holdings Limited | 138.64M | 0.81% | 99,797 | 762.00K |
| 345 | ADAG | Adagene Inc. | 133.85M | -5.96% | 10,230 | 103.20K |
| 346 | ORMP | Oramed Pharmaceuticals Inc. | 130.75M | -3.67% | 123,587 | 2.00M |
| 347 | PLYX | Polaryx Therapeutics, Inc. | 129.72M | 4.58% | 139,049 | - |
| 348 | SPRO | Spero Therapeutics, Inc. | 129.58M | 0.44% | 142,308 | 40.55M |
| 349 | CRDF | Cardiff Oncology, Inc. | 128.53M | 0.53% | 428,502 | 593.00K |
| 350 | AARD | Aardvark Therapeutics, Inc. | 127.37M | 1.92% | 350,971 | - |
| 351 | ACOG | Alpha Cognition Inc. | 125.89M | 0.87% | 67,555 | 7.43M |
| 352 | BDTX | Black Diamond Therapeutics, Inc. | 122.50M | 4.88% | 1,061,103 | 70.00M |
| 353 | GNLX | Genelux Corporation | 120.01M | 0.74% | 185,467 | 8.00K |
| 354 | INO | Inovio Pharmaceuticals, Inc. | 119.54M | 3.57% | 583,053 | 182.34K |
| 355 | GANX | Gain Therapeutics, Inc. | 117.31M | 21.51% | 1,530,141 | - |
| 356 | GOSS | Gossamer Bio, Inc. | 115.89M | -4.04% | 12,042,461 | 44.05M |
| 357 | ONCY | Oncolytics Biotech Inc. | 114.06M | 0.95% | 893,916 | - |
| 358 | COYA | Coya Therapeutics, Inc. | 112.31M | 1.05% | 89,507 | 3.99M |
| 359 | CDXS | Codexis, Inc. | 111.10M | -2.38% | 1,779,495 | 52.93M |
| 360 | DTIL | Precision BioSciences, Inc. | 110.97M | 1.77% | 82,541 | 698.00K |
| 361 | EQ | Equillium, Inc. | 107.78M | 0.57% | 232,906 | 4.39M |
| 362 | KRRO | Korro Bio, Inc. | 105.29M | 2.10% | 65,414 | 7.37M |
| 363 | FBIO | Fortress Biotech, Inc. | 103.67M | 6.71% | 706,818 | 62.30M |
| 364 | TTRX | Turn Therapeutics Inc. | 103.06M | 3.55% | 32,057 | - |
| 365 | AGEN | Agenus Inc. | 100.66M | 1.37% | 413,938 | 106.83M |
| 366 | SEER | Seer, Inc. | 100.43M | -3.26% | 151,340 | 16.58M |
| 367 | BMEA | Biomea Fusion, Inc. | 98.28M | 1.46% | 527,874 | - |
| 368 | SAVA | Cassava Sciences, Inc. | 98.07M | -0.49% | 676,814 | - |
| 369 | DWTX | Dogwood Therapeutics, Inc. | 96.22M | 1.05% | 19,877 | - |
| 370 | ANIX | Anixa Biosciences, Inc. | 95.13M | -1.38% | 87,903 | - |
| 371 | VANI | Vivani Medical, Inc. | 93.43M | 1.74% | 156,708 | - |
| 372 | HURA | TuHURA Biosciences, Inc. | 91.08M | -3.85% | 462,237 | - |
| 373 | CGTX | Cognition Therapeutics, Inc. | 90.92M | -0.96% | 508,795 | - |
| 374 | MAIA | MAIA Biotechnology, Inc. | 90.34M | 0.65% | 1,356,180 | - |
| 375 | IBIO | iBio, Inc. | 90.16M | -1.14% | 335,208 | 300.00K |
| 376 | KZIA | Kazia Therapeutics Limited | 89.89M | -3.06% | 134,303 | 1.20M |
| 377 | PMVP | PMV Pharmaceuticals, Inc. | 87.27M | 7.19% | 1,080,025 | - |
| 378 | PYXS | Pyxis Oncology, Inc. | 85.30M | 1.48% | 273,543 | 2.82M |
| 379 | OKYO | OKYO Pharma Limited | 85.27M | -1.78% | 53,512 | - |
| 380 | VRCA | Verrica Pharmaceuticals Inc. | 84.91M | 2.12% | 71,433 | 30.83M |
| 381 | MCRB | Seres Therapeutics, Inc. | 82.59M | -4.10% | 28,919 | 351.00K |
| 382 | PLRX | Pliant Therapeutics, Inc. | 81.73M | 3.10% | 374,413 | - |
| 383 | CSBR | Champions Oncology, Inc. | 81.51M | 2.44% | 3,276 | 58.42M |
| 384 | ATYR | aTyr Pharma, Inc. | 80.79M | -8.68% | 1,672,661 | 190.00K |
| 385 | PYPD | PolyPid Ltd. | 79.96M | -0.95% | 36,310 | - |
| 386 | ANTX | AN2 Therapeutics, Inc. | 78.10M | 66.67% | 6,979,562 | - |
| 387 | COEP | Coeptis Therapeutics Holdings, Inc. | 74.92M | 5.86% | 73,569 | 501.00K |
| 388 | PTHS | Pelthos Therapeutics Inc. | 74.81M | 3.17% | 2,575 | 7.41M |
| 389 | ACET | Adicet Bio, Inc. | 73.67M | -2.28% | 56,771 | - |
| 390 | GUTS | Fractyl Health, Inc. | 73.62M | -3.73% | 2,291,097 | 3.00K |
| 391 | XBIT | XBiotech Inc. | 71.19M | 1.08% | 52,447 | - |
| 392 | IBO | Impact BioMedical Inc. | 70.35M | 4.65% | 7,328,483 | 25.00K |
| 393 | CING | Cingulate Inc. | 66.99M | -1.98% | 348,248 | - |
| 394 | MNOV | MediciNova, Inc. | 66.94M | 4.62% | 40,162 | 409.66K |
| 395 | ACTU | Actuate Therapeutics, Inc. | 66.48M | -10.63% | 83,287 | - |
| 396 | ANVS | Annovis Bio, Inc. | 65.99M | 0.40% | 171,316 | - |
| 397 | IFRX | InflaRx N.V. | 65.71M | 5.42% | 373,803 | 73.73K |
| 398 | QTTB | Q32 Bio Inc. | 65.66M | 3.52% | 265,715 | - |
| 399 | TCRX | TScan Therapeutics, Inc. | 63.56M | -0.88% | 716,500 | 10.33M |
| 400 | IMA | ImageneBio, Inc. | 62.84M | -2.32% | 3,870 | 800.00K |
| 401 | MREO | Mereo BioPharma Group plc | 62.71M | 0.79% | 815,247 | 500.00K |
| 402 | EXOZ | eXoZymes, Inc. | 61.43M | -2.82% | 3,280 | -700.00 |
| 403 | NRXS | NeurAxis, Inc. | 60.83M | -2.89% | 48,961 | 3.36M |
| 404 | TIL | Instil Bio, Inc. | 60.16M | 3.74% | 43,781 | - |
| 405 | SPRB | Spruce Biosciences, Inc. | 59.80M | 3.89% | 25,019 | 697.00K |
| 406 | GRCE | Grace Therapeutics, Inc. | 59.73M | 2.66% | 148,690 | - |
| 407 | ICCC | ImmuCell Corporation | 59.70M | 3.94% | 15,303 | 27.64M |
| 408 | BYSI | BeyondSpring Inc. | 59.63M | -2.68% | 27,176 | 1.88M |
| 409 | RLYB | Rallybio Corporation | 57.71M | 1.02% | 137,672 | 674.00K |
| 410 | ENTX | Entera Bio Ltd. | 57.32M | 1.63% | 100,575 | 124.00K |
| 411 | MGX | Metagenomi Therapeutics, Inc. | 55.57M | -8.07% | 482,307 | 25.21M |
| 412 | OSTX | OS Therapies Incorporated | 55.29M | 3.97% | 671,050 | - |
| 413 | EDSA | Edesa Biotech, Inc. | 54.43M | 80.61% | 32,188,042 | - |
| 414 | NRXP | NRx Pharmaceuticals, Inc. | 54.18M | -3.95% | 464,502 | 242.00K |
| 415 | ATHE | Alterity Therapeutics Limited | 53.42M | -2.61% | 17,332 | 4.43M |
| 416 | NTRB | Nutriband Inc. | 53.00M | 2.83% | 27,990 | 2.28M |
| 417 | RADX | Radiopharm Theranostics Limited | 52.22M | 6.85% | 129,732 | 10.86M |
| 418 | HYFT | MindWalk Holdings Corp. | 51.83M | -5.13% | 3,330,599 | 19.02M |
| 419 | PSTV | Plus Therapeutics, Inc. | 51.07M | -2.89% | 3,179,713 | 5.26M |
| 420 | KZR | Kezar Life Sciences, Inc. | 50.90M | 1.76% | 26,419 | - |
| 421 | KLTO | Klotho Neurosciences, Inc. | 49.57M | 9.16% | 3,642,982 | - |
| 422 | LONA | LeonaBio, Inc. | 49.48M | -1.30% | 12,517 | - |
| 423 | ACRV | Acrivon Therapeutics, Inc. | 48.91M | -3.13% | 475,222 | - |
| 424 | INKT | MiNK Therapeutics, Inc. | 48.26M | -6.12% | 6,170 | - |
| 425 | LPCN | Lipocine Inc. | 45.14M | -0.73% | 61,642 | 4.32M |
| 426 | ESLA | Estrella Immunopharma, Inc. | 44.98M | -2.73% | 9,319 | - |
| 427 | APLM | Apollomics, Inc. | 43.05M | -0.50% | 32,789 | 6.93M |
| 428 | TELO | Telomir Pharmaceuticals, Inc. | 42.98M | -3.85% | 66,905 | - |
| 429 | ALGS | Aligos Therapeutics, Inc. | 42.95M | 4.80% | 87,186 | 2.19M |
| 430 | NXTC | NextCure, Inc. | 42.31M | -5.41% | 80,651 | - |
| 431 | LITS | Lite Strategy, Inc. | 41.45M | 0.88% | 302,275 | - |
| 432 | OKUR | OnKure Therapeutics, Inc. | 41.32M | -3.48% | 500,576 | - |
| 433 | PTN | Palatin Technologies, Inc. | 40.55M | 8.02% | 18,267 | 8.96M |
| 434 | VERU | Veru Inc. | 39.64M | -3.52% | 93,885 | 16.89M |
| 435 | ATOS | Atossa Therapeutics, Inc. | 39.01M | -3.21% | 46,176 | - |
| 436 | XLO | Xilio Therapeutics, Inc. | 38.93M | -2.11% | 454,514 | 31.80M |
| 437 | JSPR | Jasper Therapeutics, Inc. | 38.62M | 0.73% | 1,174,067 | - |
| 438 | CRVO | CervoMed Inc. | 38.03M | 2.49% | 45,522 | 6.16M |
| 439 | SNSE | Sensei Biotherapeutics, Inc. | 37.96M | -1.64% | 117,383 | - |
| 440 | ATNM | Actinium Pharmaceuticals, Inc. | 37.44M | 1.69% | 43,822 | 90.00K |
| 441 | ATRA | Atara Biotherapeutics, Inc. | 37.28M | 3.40% | 3,201,173 | 151.93M |
| 442 | LSTA | Lisata Therapeutics, Inc. | 36.87M | -1.18% | 231,303 | 1.07M |
| 443 | TVRD | Tvardi Therapeutics, Inc. | 36.87M | -2.24% | 53,450 | - |
| 444 | PDSB | PDS Biotechnology Corporation | 36.82M | 1.89% | 199,784 | - |
| 445 | NBY | NovaBay Pharmaceuticals, Inc. | 36.31M | -6.08% | 1,296,918 | 10.30M |
| 446 | INMB | INmune Bio Inc. | 35.36M | 5.14% | 1,201,178 | 50.00K |
| 447 | CELU | Celularity Inc. | 34.89M | 0.83% | 16,222 | 40.58M |
| 448 | PLUR | Pluri Inc. | 34.78M | 2.67% | 2,066 | 1.34M |
| 449 | OTLK | Outlook Therapeutics, Inc. | 34.39M | -4.12% | 1,927,643 | 205.70K |
| 450 | ABVC | ABVC BioPharma, Inc. | 33.09M | -4.96% | 30,872 | 797.92K |
| 451 | RNTX | Rein Therapeutics Inc. | 32.07M | 2.52% | 77,241 | - |
| 452 | CVM | CEL-SCI Corporation | 31.89M | -1.50% | 63,790 | - |
| 453 | TPST | Tempest Therapeutics, Inc. | 31.14M | - | 36,274 | - |
| 454 | HOWL | Werewolf Therapeutics, Inc. | 30.67M | 1.71% | 462,720 | 1.14M |
| 455 | LTRN | Lantern Pharma Inc. | 30.20M | -1.10% | 17,492 | - |
| 456 | TVGN | Tevogen Bio Holdings Inc. | 29.46M | -5.80% | 230,962 | - |
| 457 | FBLG | FibroBiologics, Inc. | 29.40M | 3.77% | 679,833 | - |
| 458 | RNXT | RenovoRx, Inc. | 28.96M | -5.98% | 475,993 | 928.00K |
| 459 | NRSN | NeuroSense Therapeutics Ltd. | 28.92M | 1.38% | 67,701 | - |
| 460 | DYAI | Dyadic International, Inc. | 27.78M | 0.99% | 44,806 | 3.34M |
| 461 | KYNB | Kyntra Bio, Inc. | 27.71M | -0.58% | 54,751 | 8.30M |
| 462 | BCTX | BriaCell Therapeutics Corp. | 27.53M | -3.74% | 188,426 | - |
| 463 | IGC | IGC Pharma, Inc. | 27.39M | 0.32% | 222,994 | 1.11M |
| 464 | CUE | Cue Biopharma, Inc. | 27.35M | 4.17% | 601,305 | 7.10M |
| 465 | AEON | AEON Biopharma, Inc. | 26.82M | 2.91% | 38,746 | - |
| 466 | PASG | Passage Bio, Inc. | 26.70M | 3.45% | 66,082 | - |
| 467 | EVAX | Evaxion A/S | 26.52M | -6.47% | 29,900 | 7.53M |
| 468 | XCUR | Exicure, Inc. | 26.45M | 4.01% | 6,936 | 500.00K |
| 469 | HYPD | Hyperion DeFi, Inc. | 26.12M | 0.32% | 79,732 | 345.32K |
| 470 | SNTI | Senti Biosciences, Inc. | 25.37M | 2.86% | 152,583 | - |
| 471 | BOLD | Boundless Bio, Inc. | 25.29M | 0.89% | 51,393 | - |
| 472 | BRNS | Barinthus Biotherapeutics plc | 24.62M | 2.05% | 45,206 | 14.97M |
| 473 | VTGN | Vistagen Therapeutics, Inc. | 24.08M | -1.07% | 660,807 | 789.00K |
| 474 | NEUP | Neuphoria Therapeutics Inc. | 23.29M | -4.85% | 71,348 | 14.99M |
| 475 | SKYE | Skye Bioscience, Inc. | 23.09M | -2.38% | 166,249 | - |
| 476 | MRKR | Marker Therapeutics, Inc. | 23.01M | -0.72% | 50,086 | 4.69M |
| 477 | DARE | Daré Bioscience, Inc. | 21.86M | -2.55% | 57,324 | -57.13K |
| 478 | IOBT | IO Biotech, Inc. | 21.62M | -7.77% | 684,632 | - |
| 479 | LIXT | Lixte Biotechnology Holdings, Inc. | 21.26M | -8.61% | 47,123 | - |
| 480 | PLRZ | Polyrizon Ltd. | 20.90M | -3.67% | 23,025 | - |
| 481 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 20.87M | -15.52% | 9,465,859 | - |
| 482 | NNVC | NanoViricides, Inc. | 20.72M | 3.61% | 155,467 | - |
| 483 | LEXX | Lexaria Bioscience Corp. | 20.63M | 7.09% | 214,953 | 522.00K |
| 484 | GNTA | Genenta Science S.p.A. | 20.15M | -5.16% | 64,714 | - |
| 485 | INTS | Intensity Therapeutics, Inc. | 20.14M | 2.98% | 25,337 | - |
| 486 | ALLR | Allarity Therapeutics, Inc. | 19.94M | 21.57% | 591,378 | - |
| 487 | VYNE | VYNE Therapeutics Inc. | 19.83M | 2.16% | 45,867 | 570.00K |
| 488 | CVKD | Cadrenal Therapeutics, Inc. | 19.36M | 3.50% | 16,084 | - |
| 489 | CTXR | Citius Pharmaceuticals, Inc. | 18.69M | -11.97% | 941,597 | 3.94M |
| 490 | KTTA | Pasithea Therapeutics Corp. | 18.39M | 0.82% | 82,263 | - |
| 491 | INAB | IN8bio, Inc. | 16.80M | -1.15% | 9,287 | - |
| 492 | SER | Serina Therapeutics, Inc. | 16.50M | -2.55% | 97,931 | 116.00K |
| 493 | HOTH | Hoth Therapeutics, Inc. | 15.41M | -1.68% | 245,873 | - |
| 494 | GTBP | GT Biopharma, Inc. | 14.81M | -0.15% | 511,242 | - |
| 495 | QNRX | Quoin Pharmaceuticals, Ltd. | 14.60M | 1.17% | 13,037 | - |
| 496 | COCP | Cocrystal Pharma, Inc. | 13.92M | 1.01% | 17,155 | - |
| 497 | QNTM | Quantum BioPharma Ltd. | 13.70M | -2.51% | 53,663 | - |
| 498 | CRIS | Curis, Inc. | 13.56M | -2.94% | 30,741 | 11.65M |
| 499 | JUNS | Jupiter Neurosciences, Inc. | 13.32M | -7.84% | 497,873 | - |
| 500 | OSRH | OSR Holdings, Inc. | 13.18M | 9.47% | 554,066 | -90.52K |
| 501 | KAPA | Kairos Pharma, Ltd. | 13.12M | -3.98% | 152,406 | - |
| 502 | TRAW | Traws Pharma, Inc. | 12.79M | - | 63,345 | 2.85M |
| 503 | BLRX | BioLineRx Ltd. | 12.68M | -2.21% | 9,538 | 12.74M |
| 504 | NCEL | NewcelX Ltd. | 12.63M | -1.77% | 7,723 | - |
| 505 | BCDA | BioCardia, Inc. | 12.52M | -2.07% | 104,165 | 3.00K |
| 506 | PHIO | Phio Pharmaceuticals Corp. | 12.49M | -0.85% | 328,399 | - |
| 507 | BCAB | BioAtla, Inc. | 12.46M | -0.06% | 1,227,213 | 11.00M |
| 508 | GDTC | CytoMed Therapeutics Limited | 12.12M | 0.96% | 2,255 | 573.19K |
| 509 | SNGX | Soligenix, Inc. | 12.00M | 3.48% | 93,289 | 2.34K |
| 510 | CLRB | Cellectar Biosciences, Inc. | 11.75M | - | 98,160 | - |
| 511 | CMMB | Chemomab Therapeutics Ltd. | 11.57M | 2.73% | 51,557 | - |
| 512 | CALC | CalciMedica, Inc. | 11.45M | 9.98% | 656,250 | - |
| 513 | AKTX | Akari Therapeutics, Plc | 11.37M | 1.87% | 153,593 | - |
| 514 | IMNN | Imunon, Inc. | 11.02M | -2.99% | 19,382 | - |
| 515 | PHGE | BiomX Inc. | 10.85M | 18.43% | 161,330 | - |
| 516 | LIMN | Liminatus Pharma, Inc. | 10.42M | -11.03% | 1,109,332 | - |
| 517 | LGVN | Longeveron Inc. | 10.32M | -2.48% | 231,194 | 1.44M |
| 518 | MBRX | Moleculin Biotech, Inc. | 10.26M | -7.14% | 180,518 | - |
| 519 | BIVI | BioVie Inc. | 10.26M | 1.49% | 30,569 | - |
| 520 | CDIO | Cardio Diagnostics Holdings, Inc. | 9.68M | -1.30% | 609,106 | 15.78K |
| 521 | ICU | SeaStar Medical Holding Corporation | 9.08M | -2.33% | 39,699 | 881.00K |
| 522 | NCNA | NuCana plc | 8.99M | 10.20% | 103,548 | - |
| 523 | RNAZ | TransCode Therapeutics, Inc. | 8.80M | 2.89% | 11,442 | - |
| 524 | ITRM | Iterum Therapeutics plc | 8.74M | -1.08% | 612,994 | 390.00K |
| 525 | CLGN | CollPlant Biotechnologies Ltd. | 8.73M | -4.52% | 12,117 | 2.48M |
| 526 | BOLT | Bolt Biotherapeutics, Inc. | 8.25M | -1.15% | 11,312 | 5.20M |
| 527 | PMCB | PharmaCyte Biotech, Inc. | 8.08M | 15.72% | 481,953 | - |
| 528 | TCRT | Alaunos Therapeutics, Inc. | 8.06M | 6.02% | 25,664 | 6.00K |
| 529 | KALA | KALA BIO, Inc. | 7.86M | 1.13% | 1,780,205 | - |
| 530 | ERNA | Ernexa Therapeutics Inc. | 7.72M | -7.17% | 501,810 | 1,000.00 |
| 531 | ALZN | Alzamend Neuro, Inc. | 7.53M | 1.54% | 29,957 | - |
| 532 | ADXN | Addex Therapeutics Ltd | 7.49M | -4.82% | 951 | 198.82K |
| 533 | GRDX | GridAI Technologies Corp. | 7.40M | -0.90% | 92,780 | - |
| 534 | PULM | Pulmatrix, Inc. | 7.38M | -5.61% | 50,996 | 3.00K |
| 535 | KPRX | Kiora Pharmaceuticals, Inc. | 7.26M | -2.46% | 45,313 | 20.00K |
| 536 | EVGN | Evogene Ltd. | 6.93M | -2.38% | 40,216 | 8.02M |
| 537 | IMRN | Immuron Limited | 6.88M | 12.82% | 49,636 | 4.99M |
| 538 | MLEC | Moolec Science SA | 6.79M | -0.64% | 22,448 | 7.83M |
| 539 | CELZ | Creative Medical Technology Holdings, Inc. | 6.57M | 1.62% | 8,274 | 6.00K |
| 540 | APM | Aptorum Group Limited | 6.56M | 0.63% | 24,630 | - |
| 541 | MBIO | Mustang Bio, Inc. | 6.54M | -5.58% | 41,407 | - |
| 542 | TOVX | Theriva Biologics, Inc. | 6.45M | -1.95% | 1,664,623 | - |
| 543 | XTLB | XTL Biopharmaceuticals Ltd. | 6.43M | 2.45% | 9,093 | 968.00K |
| 544 | PCSA | Processa Pharmaceuticals, Inc. | 6.41M | -0.70% | 28,223 | - |
| 545 | APVO | Aptevo Therapeutics Inc. | 6.39M | -0.93% | 5,477 | - |
| 546 | CANF | Can-Fite BioPharma Ltd. | 6.38M | -1.09% | 334,954 | 560.00K |
| 547 | APRE | Aprea Therapeutics, Inc. | 6.30M | -2.33% | 103,069 | 488.24K |
| 548 | PPBT | Purple Biotech Ltd | 6.01M | -1.75% | 11,341 | - |
| 549 | ASBP | Aspire Biopharma Holdings, Inc. | 5.83M | -11.45% | 231,550 | 1.94K |
| 550 | PBM | Psyence Biomedical Ltd. | 5.76M | -1.95% | 26,524 | - |
| 551 | QNCX | Quince Therapeutics, Inc. | 5.70M | -6.49% | 32,889,608 | - |
| 552 | LNAI | Lunai Bioworks Inc. | 5.62M | -35.77% | 1,026,656 | - |
| 553 | SLXN | Silexion Therapeutics Corp | 5.41M | 4.85% | 22,219 | - |
| 554 | CYCN | Cyclerion Therapeutics, Inc. | 5.37M | 1.44% | 26,168 | 2.86M |
| 555 | XBIO | Xenetic Biosciences, Inc. | 5.25M | 0.88% | 3,621 | 2.86M |
| 556 | MTVA | MetaVia Inc. | 4.97M | -2.52% | 68,244 | - |
| 557 | REVB | Revelation Biosciences, Inc. | 4.80M | 4.03% | 80,494 | - |
| 558 | VIVS | VivoSim Labs, Inc. | 4.77M | -2.66% | 28,989 | 142.00K |
| 559 | GOVX | GeoVax Labs, Inc. | 4.70M | 2.87% | 88,317 | 3.35M |
| 560 | BGMS | Bio Green Med Solution, Inc. | 4.66M | -1.05% | 19,054 | 81.00K |
| 561 | BRTX | BioRestorative Therapies, Inc. | 4.56M | 1.14% | 2,669,253 | 383.40K |
| 562 | GNPX | Genprex, Inc. | 4.52M | -2.50% | 316,359 | - |
| 563 | SILO | Silo Pharma, Inc. | 4.36M | -6.37% | 138,035 | 72.10K |
| 564 | GLMD | Galmed Pharmaceuticals Ltd. | 4.34M | 4.76% | 51,929 | - |
| 565 | INDP | Indaptus Therapeutics, Inc. | 4.15M | -2.63% | 29,695 | - |
| 566 | DCOY | Decoy Therapeutics Inc. | 4.03M | 8.46% | 166,536 | - |
| 567 | MTNB | Matinas BioPharma Holdings, Inc. | 3.85M | 4.34% | 23,744 | - |
| 568 | OGEN | Oragenics, Inc. | 3.84M | 1.28% | 208,673 | - |
| 569 | GRI | GRI Bio, Inc. | 3.71M | 6.88% | 40,284 | - |
| 570 | HCWB | HCW Biologics Inc. | 3.57M | -1.56% | 92,496 | 422.03K |
| 571 | ACXP | Acurx Pharmaceuticals, Inc. | 3.44M | -6.90% | 63,993 | - |
| 572 | SPRC | SciSparc Ltd. | 3.15M | 0.18% | 22,838 | 1.31M |
| 573 | XRTX | XORTX Therapeutics Inc. | 3.05M | 7.75% | 51,040 | - |
| 574 | DRMA | Dermata Therapeutics, Inc. | 2.98M | 3.31% | 119,390 | - |
| 575 | AZTR | Azitra, Inc. | 2.92M | 2.50% | 327,377 | 7.50K |
| 576 | SCNI | Scinai Immunotherapeutics Ltd. | 2.71M | -4.06% | 566,592 | 1.15M |
| 577 | ENVB | Enveric Biosciences, Inc. | 2.70M | -1.77% | 41,154 | - |
| 578 | PPCB | Propanc Biopharma, Inc. | 2.68M | 0.48% | 784,384 | - |
| 579 | JAGX | Jaguar Health, Inc. | 2.68M | -1.94% | 336,879 | 11.79M |
| 580 | CLDI | Calidi Biotherapeutics, Inc. | 2.64M | -53.14% | 4,631,115 | - |
| 581 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 2.64M | -0.49% | 42,762 | 1.36M |
| 582 | ARTL | Artelo Biosciences, Inc. | 2.42M | -2.56% | 61,921 | - |
| 583 | ELAB | PMGC Holdings Inc. | 2.40M | 4.85% | 239,609 | 285.95K |
| 584 | BBLG | Bone Biologics Corporation | 2.30M | 4.92% | 27,734 | - |
| 585 | LYRA | Lyra Therapeutics, Inc. | 2.27M | -0.91% | 14,714 | 600.00K |
| 586 | CMND | Clearmind Medicine Inc. | 2.05M | 5.56% | 16,154 | - |
| 587 | ADIL | Adial Pharmaceuticals, Inc. | 2.03M | -7.11% | 99,158 | - |
| 588 | ENSC | Ensysce Biosciences, Inc. | 1.99M | 1.52% | 709,452 | 4.49M |
| 589 | CDT | CDT Equity Inc. | 1.94M | 0.43% | 38,128 | - |
| 590 | CNSP | CNS Pharmaceuticals, Inc. | 1.82M | -2.00% | 22,735 | - |
| 591 | VRAX | Virax Biolabs Group Limited | 1.59M | 3.62% | 72,284 | 2.99K |
| 592 | ADTX | Aditxt, Inc. | 826.92K | 7.31% | 184,866 | 5.95K |
| 593 | BDRX | Biodexa Pharmaceuticals Plc | 759.94K | -4.37% | 63,834 | 104.90K |
| 594 | ONCO | Onconetix, Inc. | 758.85K | -14.39% | 298,799 | 1.22M |